Page last updated: 2024-08-22

galactosamine and methyl 3,4-dihydroxybenzoate

galactosamine has been researched along with methyl 3,4-dihydroxybenzoate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, L; Wan, X; Wang, X; Wu, H; Wu, L; Xiang, Y; Xie, Y; Zhang, Q	1

Other Studies

1 other study(ies) available for galactosamine and methyl 3,4-dihydroxybenzoate

Article	Year
Methyl 3,4-dihydroxybenzoate protects against d-galN/LPS-induced acute liver injury by inhibiting inflammation and apoptosis in mice. The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:7 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; bcl-Associated Death Protein; bcl-X Protein; Chemical and Drug Induced Liver Injury; Galactosamine; Hydroxybenzoates; Inflammation; Interleukin-6; Lipopolysaccharides; Liver; Male; Mice; NF-kappa B p50 Subunit; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2019

Article

Year

Methyl 3,4-dihydroxybenzoate protects against d-galN/LPS-induced acute liver injury by inhibiting inflammation and apoptosis in mice.

The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:7

Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; bcl-Associated Death Protein; bcl-X Protein; Chemical and Drug Induced Liver Injury; Galactosamine; Hydroxybenzoates; Inflammation; Interleukin-6; Lipopolysaccharides; Liver; Male; Mice; NF-kappa B p50 Subunit; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2019